Lactose board to consider forfeiture of 15,00,000 warrants on June 18

lactose has scheduled a board meeting for June 18, 2026, to consider the forfeiture of 15,00,000 convertible share warrants. The warrants were allotted on a preferential basis to M/s. SG General Dealers LLP. The forfeiture action is being taken due to the non-payment of the balance consideration required for the conversion of these warrants into equity shares within the stipulated period.

The board will address the non-compliance regarding the terms of the issue and the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The meeting will also consider any other business with the permission of the chair.

Agenda Details

The primary agenda item for the meeting is the forfeiture of the warrants. The specific details of the warrants and the reason for the proposed forfeiture are outlined below:

Agenda Item	Details
Entity	M/s. SG General Dealers LLP
Number of Warrants	15,00,000
Type	Convertible share warrants
Basis of Allotment	Preferential basis
Reason for Forfeiture	Non-payment of balance consideration for conversion

The meeting is set to take place at 15:00 p.m. at the corporate office in Mumbai. The intimation was submitted to BSE Limited pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.06%	-6.42%	-15.95%	-8.89%	+1.49%	+195.22%

Lactose (India) Limited has announced its audited financial results for the fourth quarter and financial year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 20, 2026. Statutory auditors M/s. DMKH & Co. issued an audit report with an unmodified opinion on the financial results.

For the financial year ended March 31, 2026, the company reported a net profit of ₹606.28 lakh, an increase of 17.4% from ₹516.29 lakh in the previous year. Revenue from operations rose significantly by 40.3% to ₹16,329.01 lakh from ₹11,639.93 lakh in FY25. Total income for the year stood at ₹16,436.20 lakh.

Financial Performance for FY26

The company's profitability improved alongside revenue growth. Profit before tax for the year increased to ₹862.01 lakh from ₹691.78 lakh in the prior year. Basic earnings per share (EPS) for the year rose to ₹4.82 from ₹4.10 in the corresponding period last year.

The following table summarizes the key financial metrics for the year ended March 31, 2026, compared to the previous year:

Particulars	Year Ended 31-Mar-26 (₹ in Lakhs)	Year Ended 31-Mar-25 (₹ in Lakhs)
Revenue from operations	16,329.01	11,639.93
Total Income	16,436.20	11,785.32
Total Expenses	15,574.20	11,093.54
Profit before tax	862.01	691.78
Net Profit	606.28	516.29
Basic EPS (₹)	4.82	4.10

Quarterly Results and Segment Information

For the quarter ended March 31, 2026, the company reported a net profit of ₹187.69 lakh, compared to ₹64.22 lakh in the same quarter of the previous year. Revenue from operations for the quarter stood at ₹4,576.61 lakh. Lactose (India) Limited operates in a single reportable business segment, Pharmaceuticals.

Corporate Developments

The Board noted that shareholders approved the Scheme of Arrangement for the merger with Vitanosh Ingredients Private Limited at an Extraordinary General Meeting held on March 28, 2026. The scheme is pending final approvals from the Securities and Exchange Board of India and the National Company Law Tribunal. Consequently, no effect of the merger has been given in the financial results for the quarter ended March 31, 2026.

Additionally, the company issued and allotted 15,00,000 convertible share warrants in December 2024, receiving ₹652.50 lakh towards 25% of the subscription amount. The company also recognized an estimated incremental impact of ₹6.54 lakhs under employee costs due to the New Labour Codes notified by the Government of India.